RECENT NEWS

The UKHSA will see its operations move from its current sites in Porton Down, Wiltshire and Colindale in North London to a new National Biosecurity Centre (NBC) in Harlow, Essex, after Government funding for the project was confirmed.

The Government has launched its new Life Sciences Sector Plan as part of its flagship Industrial Strategy, setting out a ten-year mission to harness British science and innovation to deliver long-term economic growth and a stronger, prevention-focused NHS.

The Microbiology Society has expressed concern over the UK Government’s decision to cut funding to the Fleming Fund, a flagship global health programme working to combat antimicrobial resistance (AMR) in low- and middle-income countries (LMICs).

Genomics England will help deliver the 10 Year Health Plan through its digital systems and by generating the evidence to inform how genomics could be embedded into routine care - shaping future approaches to earlier diagnosis, prevention and more personalised treatment.

Waters Corporation and Becton Dickinson (BD) have announced a definitive agreement to combine BD's Biosciences & Diagnostic Solutions business with Waters, creating an innovative life science and diagnostics leader with pioneering technologies.

Bio-Techne has announced a strategic partnership to distribute Spear Bio's next-generation ultrasensitive immunoassays, enabling the detection of low-abundance biomarkers in neurology.

Molecular diagnostics group Yourgene Health has launched LightBench Discover, a high-precision 3-in-1 instrument for genomic research laboratories conducting long-read sequencing.

Serious Hazards Of Transfusion (SHOT) has published its new Transfusion Safety Standards, covering various aspects of patient care and staff wellbeing.

The Government has announced its intention to amend the Medical Devices Regulations 2002 for Great Britain to incorporate EU Common Specifications for high-risk in vitro diagnostic (IVD) devices and to repeal regulations on Coronavirus Test Device Approvals (CTDA).

Aiforia Technologies has established a subsidiary in France to strengthen its local presence and to support its growing business in the country.

Artificial intelligence and digital pathology firm PathAI has unveiled the launch of the Precision Pathology Network (PPN), a first-of-its-kind network of digital anatomic pathology laboratories, which aims to platform expands access to latest AI products, unlock real-world data value, and fuel collaborative research with biopharma across a broad network.

Pathologists' examinations of tissue samples from skin cancer tumours improved when they were assisted by an AI tool. The assessments became more consistent and patients' prognoses were described more accurately, details a new study.

Researchers have discovered a strategy to neutralise two highly lethal henipaviruses for which there is currently no approved vaccine or cure.

Lunit, a provider of AI for cancer diagnostics and therapeutics, has announced a new collaboration with Microsoft to accelerate the delivery of AI-powered healthcare solutions.

Becton Dickinson (BD) has named Bilal Muhsin as Executive Vice President and President of BD's future Connected Care segment, as part of the company's previously announced plans to update its structure as it advances its New BD strategy.

A major report launched from the Women’s Cancer Screening Taskforce has issued a clear call to Government and NHS leaders: prioritise investment in the workforce behind breast and cervical cancer screening to deliver earlier diagnoses and improve outcomes for women across the UK.

Following the publication of the Government’s long-awaited 10 Year Plan for the future of the National Health Service, professional and industry bodies have been responding.

A new ‘innovator passport’ - to be introduced over the next two years - will allow new technology that has been robustly assessed by one NHS organisation to be easily rolled out to others.

NHS patients will be treated and cared for closer to their home by new teams of health professionals, as Prime Minister Keir Starmer revealed the long-awaited 10 Year Plan. The government describes the change as a “brand-new era for the NHS” promising to deliver one of the most seismic shifts in care in the history of the health service.

The pioneering Yellow Card Biobank, launched by the Medicines and Healthcare products Regulatory Agency (MHRA) and Genomics England, is investigating whether the risk of acute pancreatitis from GLP-1 injections for weight loss and type 2 diabetes may be influenced by a person’s genes.